Show simple item record

dc.contributor.authorSarah Mousavi
dc.contributor.authorMehdi Behi
dc.contributor.authorMohammad Reza Taghavi
dc.contributor.authorAlireza Ahmadvand
dc.contributor.authorShadi Ziaie
dc.contributor.authorMandana Moradi
dc.date.accessioned2017-09-18T10:19:30Z
dc.date.available2017-09-18T10:19:30Z
dc.date.issued2013-03-25
dc.identifier.issn17266890
dc.identifier.urihttp://dsp.sbmu.ac.ir/xmlui/handle/123456789/63840
dc.description.abstractDrug Utilization Evaluation (DUE) studies are designed to assess drug usage appropriateness. We aim to evaluate the drug utilization of intravenous ciprofloxacin and imipenem, two of the broad spectrum antibiotics that consume a significant proportion of our hospitals' outlay, in different wards of a teaching hospital in Zabol. During a 5 months period (December 2010 to May 2011), 263 patients who received imipenem or intravenous ciprofloxacin were assigned to this study. Retrospective review of patient's records was carried out. Data were converted to Defined Daily Dose (DDD) and the ratio of prescribed daily dose per DDD was calculated. Among these records, 100 patients received either imipenem or ciprofloxacin. The ratio of prescribed daily dose to DDD was 1.5 for both antibiotics. Almost all patients received empiric therapy in both groups. Only 13 patients (26%) in ciprofloxacin group and 4 patients (8%) in imipenem group received their antibiotics consistent with American Hospital Formulary System (AHFS) mentioned indication. Baseline Blood Urea Nitrogen (BUN) and serum Creatinine were ordered for only 37 patients (74%) in both groups with 15 abnormal results but dose adjustment performed just in one case with decreased renal function. In conclusion, the majority of courses with both drugs were empirically selected and continued and required lab tests for drug monitoring and dose adjustments were not performed in most cases. Educational interventions, developing a local formulary and a strict antibiotic prescribing policy for example by prior approval by an infectious disease consultant can help significantly to overcome these problems. © 2013 by School of Pharmacy.
dc.sourceIranian Journal of Pharmaceutical Research
dc.subjectCiprofloxacin
dc.subjectDrug utilization evaluation
dc.subjectHospital
dc.subjectImipenem
dc.titleDrug Utilization Evaluation of imipenem and intravenous ciprofloxacin in a teaching hospital
dc.journal.volume12
dc.journal.issueSUPPL.
dc.journal.pages157-163
dc.contributor.authorid54793351200
dc.contributor.authorid55627648400
dc.contributor.authorid55627169900
dc.contributor.authorid36940502900
dc.contributor.authorid24081929600
dc.contributor.authorid57189447032
dc.contributor.citation54793351200|60027708|Sarah Mousavi
dc.contributor.citation55627648400|60106642|Mehdi Behi
dc.contributor.citation55627169900|60106642|Mohammad Reza Taghavi
dc.contributor.citation36940502900|113098660|Alireza Ahmadvand
dc.contributor.citation24081929600|60018934|Shadi Ziaie
dc.contributor.citation57189447032|60106642|Mandana Moradi
dc.contributor.affiliationid60027708
dc.contributor.affiliationid60106642
dc.contributor.affiliationid60106642
dc.contributor.affiliationid113098660
dc.contributor.affiliationid60018934
dc.contributor.affiliationid60106642


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record